Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elevai Labs, Inc. - Common Stock (NQ: ELAB )

0.0590 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elevai Labs, Inc. - Common Stock

< Previous 1 2 3 Next >
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's Intraday Session
Via Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
From Elevai Labs Inc.
Via GlobeNewswire
Why Elevai Labs (ELAB) Stock Is Down 60% Today
Elevai Labs shares are trading lower by 60% Monday morning. The company announced the pricing of an $8.0 million public offering. 
Via Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Via Benzinga
11 Consumer Staples Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
From Elevai Labs Inc.
Via GlobeNewswire
Nasdaq Moves Lower; Levi Strauss Shares Slide
Via Benzinga
Crude Oil Jumps Over 4%; US Services PMI Revised Lower
Via Benzinga
Exposures Fossil Fuels
Dow Dips Over 100 Points; US Jobless Claims Increase To 225,000
Via Benzinga
Topics Stocks
Exposures US Equities
12 Consumer Staples Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device
From Elevai Labs Inc.
Via GlobeNewswire
7 Penny Stocks to Watch Now: ELAB, RJDG, BTTC, ATCH, CBDW, and More!
Via AB Newswire
Dow Gains Over 50 Points; Elevai Labs Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Down Over 1%; US Manufacturing PMI Falls In September
Via Benzinga
Exposures Fossil Fuels
US Stocks Edge Higher; Chicago Fed National Activity Increases In August
Via Benzinga
Topics Economy
Exposures Interest Rates
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications
From Elevai Labs Inc.
Via GlobeNewswire
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Monday's After-Market Session
Via Benzinga
Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum
From Elevai Labs Inc.
Via GlobeNewswire
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.